
NAMSA — a medical and contract research organization that works to accelerate medical device development through integrated testing, clinical research and regulatory consulting services — recently launched its Analytical Services Laboratory in Obernburg, Germany to further expand access to accelerated product development and testing services.
The company’s new facility offers European device manufacturers a facility that meets ISO 10993-18 testing requirements. It will also offer extraction, FTIR, GC-MS, LC-MS and ICP-MS services in that region.
NAMSA’s Analytical Services Laboratory opens March 6. The company will offer laboratory tours, complimentary consultations, scientific sessions, keynote addresses and a networking reception at the lab’s launch.
NAMSA operates 13 offices throughout Asia, Europe, the Middle East and North America.
Source: NAMSA